info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Necrobiosis Lipoidica Market By Treatment Type (Topical Corticosteroids, Systemic Immunosuppressants, Biologics, Others); By Route of Administration (Topical, Oral, Injectable); By End User (Dermatology Clinics, Hospitals, Wound Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Necrobiosis Lipoidica Market is projected to grow at an estimated CAGR of 5.8%, valued at USD 178.6 million in 2024, and... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Mitogen-Activated Protein Kinase (MAPK) Inhibitors Market By Inhibitor Type (BRAF Inhibitors, MEK Inhibitors, ERK Inhibitors, Multi-Kinase Inhibitors); By Application (Oncology, Inflammatory Disorders, Rare Genetic Syndromes); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Oncology Centers, Academic & Research Institutions, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitogen - Activated Protein Kinase ( MAPK ) Inhibitors Market will witness a robust CAGR of 9.8... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Antiplatelet Drugs Market By Product Type (Aspirin, Thienopyridines, P2Y12 Inhibitors, Combination Therapies); By Route of Administration (Oral, Injectable); By End User (Hospitals, Cardiology Clinics, Retail Pharmacies & Online Platforms, Specialized Cardiovascular Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiplatelet Drugs Market valued at USD 15.2 billion in 2024 and projected to reach USD 22.5 billion by 2030 at 6.5% CAGR, driven by cardiovascula... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Disseminated Intravascular Coagulation Market By Product Type (Therapeutics, Diagnostic Assays, Supportive Care Solutions); By Application (Sepsis, Trauma, Oncology, Obstetric Complications); By End User (Hospitals, Specialized Diagnostic Laboratories, Critical Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Disseminated Intravascular Coagulation ( DIC ) Market is projected to witness a robust CAGR of 6.8%, valued at U... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Hemophagocytic Lymphohistiocytosis (HLH) Market By Treatment Type (Immunosuppressive Therapy, Targeted Biologics, Stem Cell Transplantation, Supportive Care); By Disease Form (Primary HLH, Secondary HLH); By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hemophagocytic Lymphohistiocytosis (HLH) Market valued at USD 0.68 billion in 2024 and reaching USD 1.1 billion by 2030 at 8.1% CAGR, driven by ra... Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Frozen Shoulder Treatment Market By Treatment Type (Conservative Therapy, Pharmacological Intervention, Surgical Procedures); By Patient Demographics (Adults 40–70, High-Risk Comorbid Patients, Gender Segmentation); By End User (Hospitals, Outpatient Clinics & Physiotherapy Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Frozen Shoulder Treatment Market is projected to witness a steady CAGR of 6.5%, valued at an estimated USD 1.2 billion in 2024 , expected to reach around USD 1.8 b... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Fibroblast Activation Protein (FAP) Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Antibody-Based Inhibitors, Radiopharmaceutical Conjugates); By Therapeutic Indication (Oncology, Fibrotic Diseases); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Cancer and Specialty Hospitals, Academic & Research Institutions, Diagnostic Imaging Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Fibroblast Activation Protein (FAP) Inhibitors Market is estimated to be valued at USD 820 million in 2024 and is projected to reach around USD 1.45 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Fibrate Drugs Market By Drug Type (Fenofibrate, Gemfibrozil, Bezafibrate, Ciprofibrate, Pemafibrate); By Route of Administration (Oral, Parenteral [Experimental]); By Indication (Hypertriglyceridemia, Mixed Dyslipidemia, Cardiovascular Disease Prevention); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibrate Drugs Market valued at USD 2.9 billion in 2024 and projected to reach USD 4.1 billion by 2030 at 5.8% CAGR, driven by lipid lowering drugs... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Eye Drops and Lubricants Drugs Market By Product Type (Artificial Tears, Lipid-Based Lubricants, Anti-inflammatory Eye Drops, Preservative-Free Formulations, Nanoemulsion-Based Systems); By Therapeutic Indication (Dry Eye, Post-Surgical Recovery, Allergic Conjunctivitis, Meibomian Gland Dysfunction, Contact Lens Discomfort); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Eye Drops And Lubricants Drugs Market is projected to grow at a steady CAGR of 7.1% , reaching approximately USD 6.2 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Expectorant Drugs Market By Drug Type (Synthetic Expectorants, Natural/Herbal Expectorants); By Formulation (Syrup, Tablet, Capsule, Extended-Release); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By End User (Hospitals, Clinics, Homecare Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Expectorant Drugs Market is projected to grow at a steady CAGR of around 5.8% , valued at USD 7.9 billion in 2024 and anticipated to reach nearly USD 11.1 billion ... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Estrogen Receptor Modulators Market By Product Type (SERMs, SERDs, Dual Modulators & Novel Agents); By Application (Breast Cancer, Osteoporosis, Gynecological Disorders, Fertility & Contraception); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Estrogen Receptor Modulators Market is projected to grow at a CAGR of 6.8% , valued at approximately USD 11.7 billion in 2024 , and is ex... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Cough Suppressant Market By Product Type (Pharmaceutical-based, Herbal/Natural, Combination); By Route of Administration (Syrups, Lozenges, Capsules, Sprays); By Age Group (Pediatrics, Adults, Geriatrics); By Distribution Channel (Retail Pharmacies, Online Platforms, Hospitals & Clinics, Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

 Introduction And Strategic Context

The Global Cough Suppressant Market valued at USD 6.9 billion in 2024 and projected to reach USD 9.7 billion by 2030 at 5.8% CAGRRead More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Congestive Renal Failure Market By Product Type (Therapeutics, Dialysis Systems, Diagnostics & Monitoring Devices); By Application (Chronic Management, Acute Intervention); By End User (Hospitals, Specialty Renal Centers, Ambulatory & Outpatient Clinics, Home Healthcare, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Renal Failure Market is poised to witness a robust CAGR of 7.2 %, valued at around USD 12.6 billion in 2024 , and expected to ... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Chronic Ocular Surface Pain Market By Pain Mechanism (Nociceptive, Neuropathic); By Therapeutic Class (Anti-Inflammatories, Neuropathic Modulators, TRP/Sodium Channel Blockers, Regenerative Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Ocular Surface Pain Market is estimated to be worth USD 1.1 billion in 2024 , with expectations to reach USD 1.75 billion by 2030 , expanding at a steady C... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Cephalosporin Drugs Market By Generation (First, Second, Third, Fourth, Fifth); By Route of Administration (Oral, Parenteral); By Application (Respiratory, Skin & Soft Tissue, Urinary Tract, Gastrointestinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cephalosporin Drugs Market is projected to grow steadily at a CAGR of 4.9% between 2024 and 2030 , with an estimated valuation of USD 15.6 billion... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Calcium Channel Blocker Market By Drug Class (Dihydropyridines, Non-Dihydropyridines); By Application (Hypertension, Angina, Arrhythmias, Others); By End User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcium Channel Blocker Market valued at USD 8.7 billion in 2024 and projected to reach USD 12.1 billion by 2030 at 5.4% CAGR, driven by cardiovas... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Calcimimetics Market By Drug Type (Cinacalcet, Etelcalcetide, Others); By Indication (Secondary Hyperparathyroidism, Primary Hyperparathyroidism, Parathyroid Carcinoma, Others); By Route of Administration (Oral, Intravenous); By End User (Dialysis Centers, Hospitals, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcimimetics Market is forecast to grow at a steady CAGR of 6.1% , rising from approximately USD 872.5 million in 2024 to reach an estim... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Bone Resorption Inhibitors Market By Product Type (Bisphosphonates, Selective Estrogen Receptor Modulators [SERMs], Calcitonin, Monoclonal Antibodies); By Route of Administration (Oral, Parenteral [Subcutaneous, Intravenous]); By Application (Osteoporosis, Oncology-related Bone Disease, Rheumatologic Disorders, Endocrine-related Bone Loss); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Ambulatory Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Bone Resorption Inhibitors Market valued at USD 11.2 billion in 2024 and projected to reach USD 15.7 billion by 2030 at 5.8% CAGR, driven by osteo... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Benzodiazepine Drugs Market By Drug Type (Short-Acting, Long-Acting); By Application (Anxiety, Insomnia, Seizures, Alcohol Withdrawal, Preoperative Sedation); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benzodiazepine Drugs Market valued at USD 4.3 billion in 2024 and projected to reach USD 5.4 billion by 2030 at 3.9% CAGR, driven by anxiety treat... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Bacterial Vaccines Market By Vaccine Type (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Subunit & Recombinant Vaccines); By Disease Indication (Pneumococcal, Pertussis, Meningococcal, Tuberculosis, Typhoid & Cholera, Others); By Route of Administration (Injectable, Oral, Intranasal); By End User (Hospitals & Clinics, Vaccination Centers, Travel & Occupational Health Providers, Government Immunization Programs, NGOs & Multilateral Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bacterial Vaccines Market valued at USD 25.6 billion in 2024 and projected to reach USD 42.1 billion by 2030 at 8.6% CAGR, driven by vaccine devel... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Artificial Ventilation and Anaesthesia Masks Market By Product Type (Reusable Masks, Disposable Masks, Specialty Masks); By Application (Surgical & Anaesthesia, Critical Care & ICU, Emergency & Pre-Hospital); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Services, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Ventilation And Anaesthesia Masks Market will witness a robust CAGR of 7.5 %, valued at an USD 3.2 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Anxiolytics Market By Drug Class (Benzodiazepines, SSRIs, SNRIs, Azapirones [Buspirone], Antihistamines, Others [Neurosteroids, Cannabinoid-Based Compounds]); By Application (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Post-Traumatic Stress Disorder [PTSD], Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anxiolytics Market is projected to expand at an CAGR of 5.7% , valued at around USD 14.8 billion in 2024 and anticipated to reach USD 20.6 billion by 2030... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Antivertigo Agents Market By Drug Class (Antihistamines, Anticholinergics, Benzodiazepines, Beta Blockers & Calcium Channel Blockers, Others); By Route of Administration (Oral, Transdermal, Injectable, Intranasal & Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antivertigo Agents Market is estimated to reach USD 2.7 billion in 2024 , and is projected to grow to USD 3.9 billion by 2030 , expanding... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Antitussive Drugs Market By Drug Type (Opioid-Based, Non-Opioid); By Formulation (Syrup, Tablets & Capsules, Lozenges & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antitussive Drugs Market is projected to expand at an estimated CAGR of 4.8% , reaching around USD 6.9 billion by 2030 , up from approximately USD... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Antithyroid Agents Market By Drug Type (Methimazole, Propylthiouracil, Carbimazole); By Route of Administration (Oral, Liquid Formulations); By Disease Indication (Graves’ Disease, Toxic Multinodular Goiter, Thyroid Adenoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antithyroid Agents Market is estimated to be valued at USD 1.4 billion in 2024 , expected to reach USD 1.9 billion by 2030 , growing at a CAGR of around 5.1%Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Antispasmodics Drugs Market By Drug Class (Smooth Muscle Relaxants, Anticholinergics, Combination Therapies); By Application (Gastrointestinal Disorders, Urinary Tract Disorders, Menstrual Pain, Neuromuscular Spasms); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antispasmodics Drugs Market is projected to grow steadily at a CAGR of 5.6% , valued at USD 3.8 billion in 2024 and expected to reach nearly USD 5.3 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Antifibrinolytic Drugs Market By Drug Type (Tranexamic Acid, Aminocaproic Acid, Others); By Route of Administration (Intravenous, Oral, Topical/IM); By End User (Hospitals & Surgical Centers, EMS, Maternal Health Clinics, Outpatient Gynecology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antifibrinolytic Drugs Market is projected to reach approximately USD 2.6 billion by 2030 , up from an estimated USD 1.8 billion in 2024 ... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Antidotes Market By Product Type (Chemical Antidotes, Drug Overdose Antidotes, Biological/Enzymatic Antidotes); By Route of Administration (Intravenous, Oral, Intramuscular); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Emergency Supply Chains); By End User (Hospitals, Poison Control Centers, EMS, Military/Disaster Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antidotes Market valued at USD 4.2 billion in 2024 and projected to reach USD 6.2 billion by 2030 at 6.8% CAGR, driven by toxicology treatmentRead More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Aneurysm Clips Market By Material Type (Titanium, Cobalt-Chromium, Others); By Aneurysm Type (Saccular, Fusiform & Dissecting); By End User (Hospitals & Neurosurgical Centers, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysm Clips Market projected to reach USD 89.6 million by 2030 from USD 62.8 million in 2024, registering 6.1% CAGR, supported by neurosurgical... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Antiretroviral Therapy Market By Drug Class (NRTIs, NNRTIs, INSTIs, Protease Inhibitors, Entry Inhibitors); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online, Public Supply); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiretroviral Therapy Market valued at USD 34.7 billion in 2024 and projected to reach USD 51.9 billion by 2030 at 6.9% CAGR, driven by HIV treat... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Focal Segmental Glomerulosclerosis Market By Treatment Type (Corticosteroids, Calcineurin Inhibitors, Monoclonal Antibodies, Endothelin Receptor Antagonists, Emerging Biologics); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Nephrology Clinics, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Focal Segmental Glomerulosclerosis Market valued at USD 2.2 billion in 2024 and projected to reach USD 3.1 billion by 2030 at 6.1% CAGR, driven by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Orthopedic Disposables Market By Product Type (Bone Cements, Disposable Instruments, Drapes & Gowns, Casting Materials, Others); By Application (Joint Reconstruction, Trauma, Sports Medicine, Spine, Pediatrics); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orthopedic Disposables Market will grow at a steady CAGR of 6.4%, valued at USD 3.1 billion in 2024 and projected to reach around Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Membranous Nephropathy Market By Treatment Type (Pharmacological [Immunosuppressants, Biologics], Non-Pharmacological [Dialysis, Plasma Exchange, Transplant]); By Diagnostic Modality (Renal Biopsy, Urine & Blood Tests, Biomarker-Based Tests, Imaging); By End User (Hospitals, Nephrology Clinics, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Membranous Nephropathy Market projected to reach USD 2.3 billion by 2030 from USD 1.5 billion in 2024, registering 8.4% CAGR, supported by renal d... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Impetigo Treatment Market By Treatment Type (Topical Antibiotics, Oral Antibiotics, Non-Antibiotic Topicals, Adjunctive Therapies); By Route of Administration (Topical, Oral); By Distribution Channel (Retail Pharmacies & Drugstores, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Impetigo Treatment Market will witness a steady CAGR of 5.8%, valued at around USD 1.5 billion in 2024, and projected to cross USD 2.1 billion by 2030, co... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Vinblastine Sulfate Market By Product Type (Generic, Branded); By Route of Administration (Injectable, Oral [Exploratory]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online/Institutional Procurement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vinblastine Sulfate Market is projected to grow at a CAGR of 5.8%, valued at USD 145.0 million in 2024,... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Infusion Chair Market By Product Type (Manual Chairs, Semi-Automatic Chairs, Fully Automatic Chairs); By Application (Oncology, Dialysis, Rheumatology, Others); By End User (Hospitals, Ambulatory Infusion Centers, Dialysis Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Infusion Chair Market valued at USD 3.2 billion in 2024 and projected to reach USD 4.7 billion by 2030 with 6.8% CAGR, driven by healthcare infras... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Hospital Mobile X-Ray Market By Technology (Analog, Digital); By Power Source (Battery-Powered, Plug-in); By Application (Chest Imaging, Orthopedic Imaging, Abdominal & Other Applications); By End User (Large Hospitals & Academic Centers, Community/Secondary Hospitals, Specialized Care Units [ICUs, ERs, ORs]); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hospital Mobile X-Ray Market is projected to expand steadily between 2024 and 2030, with an estimated value of USD 5.7 billion in 2024, reaching nearly USD 8.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Bioactive Coating Devices Market By Product Type (Antimicrobial Coatings, Osteoconductive Coatings, Drug-Eluting Coatings, Other Coatings); By Application (Orthopedic Devices, Cardiovascular Devices, Dental Implants, Wound Care, Other Applications); By End-User (Hospitals, Clinics, Research Institutions, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Bioactive Coating Devices Market will experience robust growth in the forecast period from 2024 to 2030. Valued at approximately USD 3.5 billion in 2024, the market is expected to expand at a Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Cerumenolytic Agents Market By Product Type (Oil-Based Agents, Water-Based Agents, Non-Water/Non-Oil Agents); By Route of Administration (Ear Drops, Sprays, Irrigation Kits); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By End User (Hospitals, ENT Clinics, Households); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cerumenolytic Agents Market will witness a steady CAGR of 5.8%, valued at USD 1.6 billion in 2024, and projected to reach USD 2.2 billion by 2030, accordi... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Anticonvulsants Market By Drug Class (Barbiturates, Benzodiazepines, Hydantoins, Succinimides, Carbonic Anhydrase Inhibitors, Others); By Route of Administration (Oral, Intravenous, Nasal, Transdermal); By Indication (Epilepsy, Neuropathic Pain, Bipolar Disorder, Fibromyalgia, Migraine); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anticonvulsants Market will witness a stable CAGR of 5.95%, valued at USD 22.8 billion in 2024, and projected to reach USD 32.4 billion by 2030, according... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Ashermans Syndrome Market By Treatment Type (Hysteroscopic Adhesiolysis, Hormonal Therapy, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Asherman’s Syndrome Market will witness a steady CAGR of 7.2 %, valued at USD 1.2 billion in 2024,Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Urinary Retention Therapeutics Market By Treatment Type (Pharmacological, Minimally Invasive, Surgical); By Application (Benign Prostatic Hyperplasia, Neurogenic Bladder, Others); By End User (Hospitals, Specialty Clinics, Outpatient Centers, Home Care); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urinary Retention Therapeutics Market is expected to witness a robust growth trajectory, with a Compound Annual Growth Rate (CAGR) of approximately 5.6% from 2024 to 2030.... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Photomedicine Market by Technology (Laser Therapy, LED Therapy, Photodynamic Therapy, Other Light Modalities); By Application (Cancer Treatment, Wound Healing, Dermatology, Pain Management, Other Applications); By End-User (Hospitals, Dermatology Clinics, Aesthetic Centers, Research Institutions, Homecare Settings); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Photomedicine Market is expected to grow at a robust compound annual growth rate (CAGR) of 7.5%, valued at approximately USD 4.5 billion ... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

5-Alpha Reductase Deficiency Market By Diagnostic Type (Genetic Testing, Hormonal Assays, Imaging and Physical Evaluation); By Treatment Type (Hormone Replacement Therapy, Surgical Interventions, Psychological and Gender Support Services); By End User (Pediatric Hospitals and Specialty Clinics, Genetic Testing Laboratories, Research Institutes, Endocrinology and Urology Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global 5-Alpha Reductase Deficiency Market is on track for steady growth, with an estimated value of USD 412.5 million in 2024 and a projected market size of USD 657.8 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Gynandroblastoma Market By Tumor Subtype (Granulosa-Predominant, Sertoli-Leydig-Predominant); By Diagnostic Approach (Histopathology, Molecular Profiling, Immunohistochemistry); By Treatment Modality (Surgery, Hormone Therapy, Chemotherapy/Targeted Therapy); By End User (Tertiary Cancer Centers, Regional Hospitals, Women’s Health Clinics, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gynandroblastoma Market is poised for a notable shift over the coming years, with a robust CAGR of 8.1%, valued at USD 287 million in 2024Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Brain Abscess Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Intervention, Supportive/Adjunctive Care); By Pathogen Type (Bacterial Abscesses, Fungal Abscesses, Parasitic & Mixed Etiologies); By End User (Hospitals & Neurosurgical Centers, Specialty Clinics & Research Institutes, General Hospitals, Ambulatory & Secondary Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brain Abscess Treatment Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.0 billion by 2030 at 5.9% CAGR, driven by neurosurgi... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Orchiectomy Market By Procedure Type (Simple Orchiectomy, Subcapsular Orchiectomy, Radical Orchiectomy); By Application (Oncology, Gender-Affirming Surgery, Trauma, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orchiectomy Market is set to grow steadily between 2024 and 2030. It is valued at USD 476 million in 2024 and projected to reach nearly USD 713 million by 2030, advancing ... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Obturation System Market By Product Type (Carrier-Based Systems, Warm Vertical Compaction, Hand-Filling Methods); By Material (Gutta-Percha, Bioceramics); By End User (Dental Clinics, Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Obturation System Market will witness a steady CAGR of 6.8%, valued at USD 0.85 billion in 2024, expected to reach nearly USD 1.3 billion by 2030, accordi... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Ipilimumab Market By Product Type (Monotherapy, Combination Therapy); By Application (Melanoma, Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ipilimumab Market projected to reach USD 8.3 billion by 2030 from USD 5.2 billion in 2024, registering 8.1% CAGR, supported by melanoma treatment<... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Microneedling Market By Device Type (Manual Devices, Automated Devices); By Application (Skin Rejuvenation, Acne Scar Treatment, Hair Regrowth, Stretch Marks); By End User (Dermatology Clinics, Spas and Beauty Salons, Home-use Devices, Medical and Clinical Research Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedling Market valued at USD 1.1 billion in 2024 and projected to reach USD 2.1 billion by 2030 at 9.5% CAGR, driven by aesthetic treatments... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Thymidylate Synthase Inhibitor Market By Drug Type (5-Fluorouracil, Capecitabine, Pemetrexed, Other Thymidylate Synthase Inhibitors); By Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Other Cancers); By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Research & Academic Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Thymidylate Synthase Inhibitor Market: Oncology Drug Class Overview and Pipeline Developments (Last Updated on: June-2026)

The Global Thymidylate Synthase Inhibitor Market is expected to experience significant growth between 2024 and 2030, with a p... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Spinal Pumps Market By Product Type (Intrathecal Infusion Pumps, Epidural Infusion Pumps); By Application (Chronic Pain Management, Spasticity, Cancer Pain); By End User (Hospitals, Pain Management Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Pumps Market will witness a robust growth trajectory, driven by increasing advancements in medical technology and a growing demand for more targeted pain management solutions. This ... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Small Lymphocytic Lymphoma Market By Product Type (Targeted Therapies, Chemotherapy, Monoclonal Antibodies, Emerging Immunotherapies); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Lymphocytic Lymphoma (SLL) Market will witness a robust CAGR of 6.8%, valued at USD 2.5 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Photostimulable Phosphor Systems Market By Product Type (Fixed Systems, Portable Systems); By Application (General Radiography, Dental, Mammography, Veterinary, Others); By End User (Hospitals, Diagnostic Imaging Centers, Dental Clinics, Veterinary Clinics, Mobile Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Photostimulable Phosphor Systems Market is forecast to register a healthy CAGR of 6.4%, standing at an estimated $3.9 billion in 2024 and projected to reach $5.7 b... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Galactosemia Treatment Market By Treatment Type (Dietary Management, Pharmacological Interventions, Enzyme Replacement Therapy, Gene Therapy); By Patient Type (Infants, Adolescents, Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Galactosemia Treatment Market valued at USD 0.42 billion in 2024 and projected to reach USD 0.65 billion by 2030 at 6.5% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Molecular Breast Imaging Market By Technology (Single-Head Gamma Camera, Dual-Head Gamma Camera); By Tracer Type (Technetium-99m Sestamibi, Emerging Radiotracers); By Application (Dense Breast Screening, Diagnostic Clarification, Therapy Response, Pre-Surgical Planning); By End User (Hospitals, Independent Imaging Centers, Specialty Breast Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Molecular Breast Imaging Market valued at USD 470 million in 2024 and projected to reach USD 770 million by 2030 at 7.5% CAGR, driven by breast im... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Adrenocorticotropic Hormone Market By Product Type (Natural ACTH, Synthetic ACTH Analogs); By Indication (Infantile Spasms, Multiple Sclerosis, Nephrotic Syndrome, Other Rare Indications); By Route of Administration (Intramuscular, Subcutaneous, Extended-Release/Depot); By End User (Hospitals & Tertiary Care, Specialty Clinics, Home Care & Specialty Pharmacy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Adrenocorticotropic Hormone Market will witness a steady CAGR of 5.9%, valued at $1.17 billion in 2024, and projected to reach $1.66 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Aromatase Deficiency Market By Therapy Type (Estrogen Replacement Therapy, Combination Hormone Therapy, Gene Therapy and Novel Endocrine Modulators); By Route of Administration (Oral, Transdermal, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Deficiency Market will witness a steady CAGR of 6.8%, valued at USD 423 million in 2024, and is expected to reach USD 628 million by 2030, accor... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Lincomycin Market By Product Form (Injection, Capsule, Granule/Powder); By Application (Human Therapeutics, Veterinary Medicine, Industrial Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lincomycin Market valued at USD 1.2 billion in 2024 and projected to reach USD 1.7 billion by 2030 at 5.6% CAGR, driven by antibiotic demandRead More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Appetite Stimulant Market By Product Type (Pharmaceuticals, Natural Supplements, Over-the-Counter Products); By Application (Cancer, Neurological Disorders, Chronic Diseases, Anorexia & Other Conditions); By End User (Hospitals & Clinics, Homecare, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Appetite Stimulant Market will witness a robust CAGR of 6.4%, valued at USD 4.3 billion in 2024, expected to appreciate and reach USD 6.5 billion<... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Medication-Assisted Treatment Market By Drug Type (Buprenorphine, Methadone, Naltrexone, Others); By Route of Administration (Oral, Sublingual, Injectable, Implantable); By Application (Opioid Use Disorder, Alcohol Use Disorder, Other Substance Use Disorders); By End User (Specialty Addiction Treatment Centers, Hospitals & Clinics, Telehealth Platforms, Correctional Facilities, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Medication-Assisted Treatment Market is poised for substantial expansion, projected to grow at a CAGR of 6.9% between 2024 and 2030. The market is currently valued at USD 4.7 billi... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Surgical Incision Closure Devices Market By Product Type (Sutures, Staplers, Adhesives & Sealants, Closure Strips & Clips); By Application (General Surgery, Orthopedic Surgery, Cardiovascular & Thoracic Surgery, Gynecology & Obstetrics, Cosmetic & Reconstructive Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Surgical Incision Closure Devices Market is projected to grow at a steady CAGR of 6.5%, valued at approximately USD 8.7 billion in 2024, and forecasted to reach US... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Extremity Tissue Expanders Market By Product Type (Rectangular Expanders, Crescent Expanders, Anatomically Shaped Expanders, Custom/3D Expanders); By Application (Trauma Reconstruction, Oncology Resections, Congenital Deformities, Burn Contracture Releases, Orthopedic Grafting Prep); By End User (Hospitals, Reconstructive Surgery Clinics, Pediatric Orthopedic Centers, Military & Burn Units, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Extremity Tissue Expanders Market valued at USD 512 million in 2024 and projected to reach USD 730 million by 2030 at 6.1% CAGR, driven by reconst... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Neurology Ultrasonic Aspirators Market by Product Type (Handheld, Fixed), by Application (Tumor Resection, Epilepsy Surgery, Neurodegenerative Diseases, Spinal Procedures), by End User (Hospitals, Specialized Surgical Centers, Ambulatory Surgical Centers, Research and Academic Institutions), by Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Neurology Ultrasonic Aspirators Market is poised for substantial growth, expected to witness a compound annual growth rate (CAGR) of 6.4%, valued at approximately USD 1.8 billion in 2024<... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Severe Hypertriglyceridemia Treatment Market By Drug Class (Fibrates, Omega-3 Derivatives, Statins, Niacin, Emerging Biologics); By Route of Administration (Oral, Injectable); By End User (Hospitals & Specialty Clinics, Retail & Hospital Pharmacies, Research & Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Severe Hypertriglyceridemia Treatment Market is projected to grow at a CAGR of 8.1%, valued at approximately USD 2.6 billion in 2024, and... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Viral Hemorrhagic Fever (VHF) Market By Pathogen Type (Filoviruses, Arenaviruses, Bunyaviruses, Flaviviruses); By Intervention (Vaccines, Antivirals & Therapeutics, Diagnostics, Surveillance Systems); By End User (Public Health Agencies, Hospitals & Clinics, Military, NGOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Hemorrhagic Fever (VHF) Market will witness a robust CAGR of 9.8%, valued at USD 1.8 billion in 2024, and expected to appreciate and reach USD 3.2 billi... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Cardioselective Beta Blockers Market By Drug Type (Metoprolol, Bisoprolol, Atenolol, Nebivolol, Others); By Application (Hypertension, Angina & Ischemic Heart Disease, Arrhythmias, Heart Failure, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Public Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardioselective Beta Blockers Market is projected to grow steadily, reaching an estimated USD 6.8 billion in 2024 and expanding to around USD 9.5 ... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Thrombocythemia Market By Treatment Type (Cytoreductive Therapy, Targeted Therapies, Antiplatelet Agents, Stem Cell Transplant and Experimental Therapies); By Diagnostic Method (Complete Blood Count, Bone Marrow Biopsy, Molecular Testing); By End User (Hospitals & Specialty Hematology Centers, Diagnostic Laboratories, Retail & Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thrombocythemia Market is projected to expand steadily, growing at an estimated CAGR of 6.1%, valued at USD 1.9 billion in 2024 and expec... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Specimen Containers Market By Product Type (Urine Containers, Stool Containers, Blood Specimen Containers, Tissue Sample Containers, Sputum & Microbiology Containers, Specialty Containers); By Material Type (Polypropylene, Polyethylene, Medical-Grade Plastics, Biodegradable Plastics); By Application (Clinical Diagnostics, Research & Academic Use, Home Collection & D2C Testing); By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Home Healthcare & Telemedicine Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Specimen Containers Market valued at USD 3.1 billion in 2024 and projected to reach USD 4.47 billion by 2030 at 6.3% CAGR, driven by medical devic... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Magnetic Resonance Elastography Market By Application (Liver, Neurology, Breast, Musculoskeletal, Others); By Component Type (Hardware, Software); By End User (Tertiary Hospitals, Imaging Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Magnetic Resonance Elastography (MRE) Market is projected to expand at a compelling CAGR of 8.1%, reaching USD 453.7 million by 2... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Amnestic Disorders Therapeutics Market By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, GABA Modulators, Neuroregenerative Agents); By Route of Administration (Oral, Injectable, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Amnestic Disorders Therapeutics Market is projected to grow at a steady pace, with an estimated value of $4.8 billion in 2024, expected to reach around $7.2 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Myelofibrosis Market By Therapy Class (JAK Inhibitors, Antifibrotic Agents, Immunotherapies, Telomerase Inhibitors); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myelofibrosis Market valued at USD 1.8 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 10.5% CAGR, driven by rare disease treatm... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Cardiovascular Drugs Market By Therapeutic Class (Antihypertensives, Statins, Anticoagulants, Antiplatelets, Biologics & RNA-based Drugs); By Application (Hypertension, Hyperlipidemia, Coronary Artery Disease, Heart Failure, Arrhythmias, Thrombosis); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Mail-Order Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Drugs Market valued at USD 155.2 billion in 2024 and projected to reach USD 214.3 billion by 2030 at 5.6% CAGR, driven by cardiovas... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Intra-Abdominal Infection Market By Infection Type (Complicated, Uncomplicated); By Drug Class (Antibiotics, Antifungals, Supportive Therapies); By Pathogen (Aerobic, Anaerobic, Mixed); By End User (Hospitals, Ambulatory Surgical Centers, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intra-Abdominal Infection Market valued at USD 8.6 billion in 2024 and projected to reach USD 12.7 billion by 2030 at 6.7% CAGR, driven by antibio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Sedative-Hypnotic Drugs Market by Drug Type (Benzodiazepines, Non-Benzodiazepine Sleep Aids, Barbiturates, Melatonin Receptor Agonists, Other Sedative-Hypnotics); By Application (Sleep Disorders, Anxiety Disorders, Severe Mental Health Disorders); By End User (Hospitals, Outpatient Clinics, Pharmacies, Research Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sedative-Hypnotic Drugs Market is projected to reach USD 5.8 billion in 2024 and is expected to grow at a CAGR of 5.8% from 2024 to 2030, reaching an esti... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Endocrine Disorders Market By Disorder Type (Diabetes, Thyroid Disorders, Adrenal Disorders, PCOS & Reproductive Endocrine Disorders, Rare Endocrine Disorders); By Treatment Modality (Pharmaceuticals, Medical Devices & Monitoring Tools, Surgical Interventions, Lifestyle & Digital Interventions); By End User (Hospitals & Specialty Clinics, Ambulatory & Outpatient Centers, Homecare & Remote Monitoring, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endocrine Disorders Market valued at USD 35.6 billion in 2024 and projected to reach USD 56.4 billion by 2030 at 6.8% CAGR, driven by hormonal dis... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Orexin Receptor Antagonist Market By Drug Type (Dual Orexin Receptor Antagonists, Selective Orexin Receptor Antagonists); By Application (Insomnia, Narcolepsy, Anxiety & Depression-Related Sleep Disorders, PTSD); By Route of Administration (Oral, Sublingual Film, Liquid Suspension, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orexin Receptor Antagonist Market is on a sharp upward trajectory. It’s estimated to be worth $2.6 billion in 2024 and is projected to reach $ 6.52 ... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Coronary Guidewires Market By Product Type (Conventional Guidewires, Specialty Guidewires); By Coating (Hydrophilic, Hydrophobic, Polymer-Coated); By Application (Angioplasty, Stent Placement, Chronic Total Occlusion); By End User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgical Centers, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Coronary Guidewires Market valued at USD 1.25 billion in 2024 and projected to reach USD 1.85 billion by 2030 at 6.5% CAGR, driven by cardiovascul... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Laryngeal Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Laryngeal Cancer Therapeutics Market projected to reach USD 4.1 billion by 2030 from USD 2.6 billion in 2024, registering 6.8% CAGR, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Fascioliasis Market by Product Type (Antiparasitic Drugs, Diagnostics, Vaccines); By End User (Veterinary Clinics & Livestock Farms, Public Health Agencies, Hospitals & Rural Health Centers, Diagnostic Laboratories); By Region (Latin America, MENA, Asia-Pacific, Europe, Sub-Saharan Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fascioliasis Market is projected to expand steadily between 2024 and 2030, with a CAGR of 5.1%, growing from approximately USD 520 million in... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Ovulation Inducing Drugs Market By Drug Type (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins, Dopamine Agonists, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ovulation Inducing Drugs Market projected to reach USD 6.9 billion by 2030 from USD 4.7 billion in 2024, registering 6.5% CAGR, supported by ferti... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Ultramicrotome Market By Product Type (Glass Knife Ultramicrotomes, Diamond Knife Ultramicrotomes, Cryo-Ultramicrotomes); By Application (Biological Research, Materials Science, Pharmaceutical R&D); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, CROs, Industrial Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ultramicrotome Market growing from USD 52.6 million in 2024 to USD 74.9 million by 2030, reflecting 6.0% CAGR growth, driven by electron microscop... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Lancets Market By Product Type (Standard Lancets, Safety Lancets); By Application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lancets Market projected to reach USD 5.09 billion by 2030 from USD 3.1 billion in 2024, registering 8.6% CAGR, supported by blood samplingRead More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Immune Thrombocytopenia (ITP) Market By Drug Class (Thrombopoietin Receptor Agonists, FcRn Inhibitors, Monoclonal Antibodies, Syk Inhibitors, Others); By Route of Administration (Oral, Parenteral, Subcutaneous); By End User (Hospitals, Specialty Hematology Clinics, Retail & Specialty Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Thrombocytopenia (ITP) Market is projected to grow at a CAGR of 6.8%, valued at approximately USD 2.5 billion in 2024 and expected to reach nearly USD 3.9 b... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Electric Impedance Tomography Market By Product Type (Standalone Systems, Integrated Ventilator-Based Modules, Wearable & Portable Devices); By Application (Pulmonary Monitoring, Neonatal & Pediatric Care, Neurological Applications, Oncology & Other Uses); By End User (Hospitals & ICUs, Specialty & Pediatric Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Electric Impedance Tomography Market valued at USD 82 million in 2024 and projected to reach USD 137 million by 2030 at 7.8% CAGR, driven by medic... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Visceral Pain Treatment Market By Treatment Type (Pharmacological Therapies, Interventional Therapies, Behavioral Therapies); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels); By Application (Gastrointestinal Disorders, Gynecological Disorders, Urological Conditions, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Visceral Pain Treatment Market valued at USD 12.5 billion in 2024 and projected to reach USD 18.6 billion by 2030 at 6.8% CAGR, driven by pain man... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Virology Testing Market By Testing Methodology (PCR, Enzyme Immunoassays, Next-Generation Sequencing, Rapid Diagnostic Tests, CRISPR-based Testing); By Application (HIV & Hepatitis Testing, Respiratory Infections, Emerging Viruses, Other Viral Infections); By End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing, Research Institutes, Home-Based Testing); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Virology Testing Market valued at USD 5.3 billion in 2024 and projected to reach USD 8.2 billion by 2030 at 6.8% CAGR, driven by infectious diseas... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Erythroid Maturation Agent Market By Drug Type (Luspatercept, Next-Gen Ligand Traps, Experimental SMAD Modulators); By Indication (Transfusion-Dependent Beta-Thalassemia, Myelodysplastic Syndromes, Others); By Route of Administration (Subcutaneous, Oral [Pipeline]); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythroid Maturation Agent Market projected to reach USD 1.65 billion by 2030 from USD 1.12 billion in 2024, registering 6.5% CAGR, supported by b... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cardiac Sarcoidosis Market By Product Type (Diagnostics, Therapeutics, Devices & Supportive Care); By Diagnostic Modality (PET, Cardiac MRI, Endomyocardial Biopsy, Blood-Based & Biomarker Tests); By Treatment Approach (Corticosteroids, Immunosuppressants, Biologics & Targeted Therapies, Device-Based Interventions); By End User (Hospitals & Specialty Cardiac Centers, Diagnostic Imaging Centers, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Sarcoidosis Market valued at USD 1.1 billion in 2024 and projected to reach USD 1.9 billion by 2030 at 8.5% CAGR, driven by cardiac diagno... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Critical Care Devices Market By Product Type (Ventilators, Patient Monitoring Systems, Infusion Pumps, Dialysis Equipment, Anesthesia Machines, Other Critical Care Devices); By Application (Respiratory Care, Cardiovascular Care, Neurological Care, Renal Care, Other Applications); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Diagnostic Imaging Centers, Emergency Medical Services); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Critical Care Devices Market growing at 6.5% CAGR, expanding from USD 10.2 billion in 2024 to USD 18.5 billion by 2030, fueled by intensive care u... Read More

Published Date: JAN-2026 | No Of Pages:161 | $ 4485

Temporal Arteritis Market By Treatment Type (Corticosteroids, Biologics [IL-6 Inhibitors, JAK Inhibitors, Others]); By Diagnostic Modality (Temporal Artery Biopsy, Ultrasound, MRI Angiography, PET-CT); By End User (Hospitals, Specialty Clinics, Diagnostic Centers, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Temporal Arteritis Market valued at USD 1.4 billion in 2024 and projected to reach USD 2.0 billion by 2030 at 5.8% CAGR, driven by autoimmune diso... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Hemorrhagic Stroke Treatment Market By Treatment Type (Drug Therapy, Surgical Intervention, Endovascular Procedures, Monitoring & Supportive Devices); By Cause/Condition (Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Other Rare Hemorrhages); By End User (Tertiary Hospitals, General Hospitals, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemorrhagic Stroke Treatment Market valued at USD 11.6 billion in 2024 and projected to reach USD 18.4 billion by 2030 at 7.9% CAGR, driven by str... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Osteomyelitis Market By Type (Acute, Chronic); By Drug Class (Antibiotics, Anti-inflammatory Drugs, Others); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteomyelitis Market valued at USD 3.1 billion in 2024 and projected to reach USD 4.3 billion by 2030 at 5.8% CAGR, driven by bone infection treat... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Swab and Viral Transport Medium Market By Product Type (Swabs [Flocked, Foam, Cotton], Viral Transport Media [Standard VTM, Molecular VTM, Dry Transport]); By Application (Infectious Diseases, STI Testing, Surveillance Programs); By End User (Hospitals & Diagnostic Labs, Point-of-Care Settings, Public Health Agencies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Swab And Viral Transport Medium Market valued at USD 1.65 billion in 2024 and projected to reach USD 2.34 billion by 2030 at 5.9% CAGR, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Topical Antibiotics Market By Product Type (Mupirocin, Fusidic Acid, Neomycin & Bacitracin, Clindamycin & Erythromycin, Others); By Formulation (Ointments & Creams, Gels & Lotions, Eye/Ear Drops, Powders & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Topical Antibiotics Market projected to reach USD 6.5 billion by 2030 from USD 4.6 billion in 2024, registering 5.9% CAGR, supported by dermatolog... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Erythropoietin Stimulating Agents (ESA) Market By Drug Type (Biologics, Biosimilars); By Application (Chronic Kidney Disease, Oncology-Associated Anemia, HIV & Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythropoietin Stimulating Agents (ESA) Market valued at USD 9.8 billion in 2024 and reaching USD 13.7 billion by 2030 at 5.7% CAGR, driven by ane... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Dilated Cardiomyopathy Market By Therapy (Pharmacological Treatments, Novel & Targeted Therapies); By Device (ICDs & CRT-Ds, LVADs, Wearable Monitoring Devices); By Diagnostic Approach (Echocardiography, Cardiac MRI, Genetic Testing); By End User (Hospitals & Cardiac Centers, Specialty Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dilated Cardiomyopathy Market valued at USD 2.9 billion in 2024 and reaching USD 4.6 billion by 2030 at 7.9% CAGR, driven by cardiovascular diseas... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Thoracoscopy Market By Product Type (Rigid Thoracoscopes, Flexible Thoracoscopes, Video-Assisted Systems, Robotic-Assisted Systems); By Application (Diagnostic Thoracoscopy, Therapeutic Thoracoscopy); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Training & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thoracoscopy Market will witness a steady CAGR of 6.8%, valued at USD 1.35 billion in 2024, and expected to reach USD 2.01 billion by 2030, confirms Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

IgG4-Related Disease Market By Treatment Type (Corticosteroids, Immunosuppressive Drugs, Biologics, Small Molecules); By Diagnostic Method (Serological Testing, Imaging, Biopsy, Digital Pathology, Biomarker Panels); By End User (Tertiary Care Hospitals, Specialty Clinics, Reference Laboratories, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global IgG4-Related Disease Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.5 billion by 2030 at 7.5% CAGR, driven by rare disease ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Clinical Communication and Collaboration Market By Component (Solutions, Services); By Deployment Mode (On-Premise, Cloud-Based); By End User (Hospitals & Health Systems, Ambulatory Surgical Centers, Physician Groups, Long-Term Care Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clinical Communication And Collaboration (CC&C) Market valued at USD 6.9 billion in 2024 and projected to reach USD 16.55 billion by 2030 at 15.7% CAGRRead More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485